Skip to content

Latest News

Reliance Industries hits all-time high, Goldman Sachs retains Buy, downgrades other oil stocks

Reliance Industries hits all-time high, Goldman Sachs retains Buy, downgrades other oil stocks

Goldman Sachs#39; 12-month target for Reliance Industries now stands at Rs 2,885 versus Rs 2,660 earlier Read More ​ Goldman Sachs#39; 12-month target for Reliance Industries now stands at Rs 2,885 versus Rs 2,660 earlier Goldman Sachs#39; 12-month target for Reliance… Read More »Reliance Industries hits all-time high, Goldman Sachs retains Buy, downgrades other oil stocks

No state govt nod for venue for starting of #39;Bharat Jodo Nyay Yatra#39;: Manipur Congress

No state govt nod for venue for starting of #39;Bharat Jodo Nyay Yatra#39;: Manipur Congress

The party termed the state government#39;s decision as a “violation of people#39;s rights”, and said an alternative place to start the proposed march is being considered. Read More ​ The party termed the state government#39;s decision as a “violation of people#39;s… Read More »No state govt nod for venue for starting of #39;Bharat Jodo Nyay Yatra#39;: Manipur Congress

ICICI Bank ends Axis’ 16-year run as rupee bond market king

ICICI Bank ends Axis’ 16-year run as rupee bond market king

India’s second-largest lender by market value managed 980.3 billion rupees ($11.8 billion) of offerings in 2023, including self-led transactions. Read More ​ India’s second-largest lender by market value managed 980.3 billion rupees ($11.8 billion) of offerings in 2023, including self-led transactions.… Read More »ICICI Bank ends Axis’ 16-year run as rupee bond market king

Aurobindo Pharma now weighs mega IPO of Eugia Pharma Specialities to raise around Rs 4,500 crore

Aurobindo Pharma now weighs mega IPO of Eugia Pharma Specialities to raise around Rs 4,500 crore

In May 2021, in a move to improve operational efficiency, Aurobindo Pharma had approved the transfer of its injectable assets into a subsidiary called Eugia Pharma Specialities Limited for “greater focus, attention and specializationâ€� and also to “augment fund-raise and… Read More »Aurobindo Pharma now weighs mega IPO of Eugia Pharma Specialities to raise around Rs 4,500 crore

en_USEnglish